/
/
/

Piramal Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)214.99
Volume (₹)19.07 L
High (₹)217.00
Upper Circuit257.38
Low (₹)210.52
Lower Circuit171.60
Prev Close214.49
52W High (₹)220.36
Price212.45
52W Low (₹)132.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)28550.80 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.68
Price to Book2.24
Book Value60.96
EPS (TTM)-2.36
Face Value10.00
ROE (%)-4.04

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
PPLPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1899.4-20.6 (-1.07%)
1896.80
1984.80
4,56,833Cr
9133-106 (-1.15%)
9087
9467
2,45,426Cr
4841-209 (-4.14%)
4823
5066
1,87,320Cr
1129.5-61.5 (-5.16%)
1125.10
1187
1,13,217Cr
1380-43.5 (-3.06%)
1376
1426.10
1,12,212Cr
1843.1-95.4 (-4.92%)
1811.70
1949
1,01,155Cr
2109-62.5 (-2.88%)
2107.20
2192
97,626Cr
2330.9-52 (-2.18%)
2327.30
2419.20
96,859Cr
1157.5-20.5 (-1.74%)
1154.40
1179.90
96,406Cr
1653.8+8.5 (0.52%)
1622.60
1717
93,614Cr
212.45-6.23 (-2.85%)
210.50
218.61
28,551Cr

Key Highlights of Piramal Pharma Ltd Balance Sheet

Piramal Pharma Ltd balance sheet discloses shareholders' funds of ₹1327.16Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹1327.16Cr, and the reserves and surplus of the company is ₹6739.1Cr.

The company has its non-current liabilities with total liabilities of ₹12309.7Cr as of 2026-03-31.

The current liabilities are ₹2882.74Cr as of 2026-03-31. At the same time, current assets are ₹4514.56Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹3486.05Cr and tangible assets of ₹3035.86Cr, provided in the Piramal Pharma Ltd financial statements.